Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
---|
01/20/2010 | CN100582107C Solvent-free process for the preparation of diketopyrrolopyrrole derivatives |
01/20/2010 | CN100582105C Quadridentate-bridged ligand, its iridium complexes and iridium-rare earth ion bimetal complexes, and preparation method and application thereof |
01/19/2010 | US7649199 N,N'-bis(4-trifluoromethylcyclohexyl)-1,4,5,8-naphthalenetetracarboxylic acid diimide;high operational voltage (high threshold voltage); good current on/off ratios in organic thin film transistor devices when operated in air; oxidation resistance; electron mobility, up to >1 cm2/Vs; solar cells |
01/19/2010 | US7649093 Naphthalene compounds as selective estrogen receptor modulators |
01/19/2010 | US7649056 Triamantane diamondoid nucleus |
01/19/2010 | US7649015 Saquinavir-like, a Lopinavir-like, a Ritonavir-like, a Indinavir-lik, a atazanavir-like, Nelfinavir-like.a Tipranavir-like, a Amprenavir-like, a KNI-like. a cyclic carbonyl-like phosphonate HIV protease inhibitors; drug designing |
01/19/2010 | US7648998 Imidazo 4,5-c pyridine compounds and methods of antiviral treatment |
01/19/2010 | US7648997 Immunomodulators for inducing cytokine biosynthesis, for treatment of diseases including viral and neoplastic diseases; 1-[3-(Aminooxy)propyl]-2-propyl-1H-imidazo[4,5-c]quinolin-4-amine; N-[3-(4-Amino-2-propyl-1H-imidazo[4,5-c]quinolin-1-yl)propoxy]cyclopropanecarboxamide |
01/19/2010 | US7648987 Bicyclic protein kinase inhibitors |
01/19/2010 | US7648986 Hypertension, atherosclerosis, restenosis, cerebral ischemia, cerebral vasospasm, or erectile dysfunction; 2-(5-chloro-2-thienyl)-N-(1H-indazol-5-yl)thieno[3,2-d]pyrimidin-4-amine |
01/19/2010 | CA2402751C Decahydro-isoquinolines |
01/19/2010 | CA2315897C Novel camptothecin tetracyclic analogues, preparation, methods, applications as medicines and pharmaceutical compositions containing them |
01/19/2010 | CA2239904C Inhibitors of interleukin-1.beta. converting enzyme |
01/14/2010 | WO2010005879A1 Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
01/14/2010 | WO2010005876A2 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
01/14/2010 | WO2010005870A1 Bis-carbazole dna intercalating agents for antitumor therapy |
01/14/2010 | WO2010005643A1 Processes for purifying varenicline l-tartrate salt and preparing crystalline forms of varenicline l-tartrate salt |
01/14/2010 | WO2010005528A2 Pyrrolopyridine carboxylic acid derivatives |
01/14/2010 | WO2010005520A2 2-alkyl-3-acylpyrazolo[1,5-a]pyridine derivatives |
01/14/2010 | WO2010004578A2 Novel and improved processes for the preparation of paliperidone |
01/14/2010 | WO2010004507A1 Thiazolidine compounds as orexin receptor antagonists |
01/14/2010 | WO2010004198A2 Antineoplastic derivatives, preparation thereof, and therapeutic use thereof |
01/14/2010 | WO2010004197A2 Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof |
01/14/2010 | WO2010003703A2 Paliperidone ketone |
01/14/2010 | WO2010003702A1 Synthesis of paliperidone |
01/14/2010 | WO2009143156A3 Imidazo [1, 2-a] pyridine compounds as gaba-a receptor modulators |
01/14/2010 | WO2009126861A3 Triazolopyridine compounds useful as dgat1 inhibitors |
01/14/2010 | WO2009126530A3 Piperidine derivatives as cgrp receptor antagonists |
01/14/2010 | US20100010221 Processes for purifying varenicline l-tartrate salt and preparing crystalline forms of varenicline l-tartrate salt |
01/14/2010 | US20100010217 Methods for the preparation of imidazole-containing compounds |
01/14/2010 | US20100010194 Method for Preparing a Polymer Conjugate |
01/14/2010 | US20100010038 Tricyclic compound and pharmaceutical use thereof |
01/14/2010 | US20100010037 1h-pyrrolo[2,3-b]pyridine derivatives useful as hsp90 inhibitors |
01/14/2010 | US20100010035 Novel Dual Action Receptors Antagonists (Dara) at the Ati and Eta Receptors |
01/14/2010 | US20100010034 Crth2 antagonists |
01/14/2010 | US20100010033 Bis-carbazole DNA intercalating agents for antitumor therapy |
01/14/2010 | US20100010015 Heterocyclic spiro-compounds as aldosterone synthase inhibitors |
01/14/2010 | US20100010007 Piperidine derivatives as modulators of chemokine receptor ccr5 |
01/14/2010 | US20100010004 Inhibitors of histone deacetylase |
01/14/2010 | US20100009993 Diketo Fused Azolopiperidines and Azolopiperazines as Anti-HIV Agents |
01/14/2010 | US20100009992 Ampk modulators |
01/14/2010 | US20100009988 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
01/14/2010 | US20100009986 Substituted heteroaryl derivatives |
01/14/2010 | US20100009979 Pharmaceuticals containing fluoroquinolones |
01/14/2010 | US20100009968 11beta-hydroxysteroid dehydrogenase type 1 active compounds |
01/14/2010 | CA2730251A1 Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
01/14/2010 | CA2730231A1 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
01/14/2010 | CA2730071A1 Antineoplastic derivatives of 4-oxo-l, 4-dihydro-quinolin?, preparation thereof, and therapeutic use thereof |
01/14/2010 | CA2729985A1 Thiazolidine compounds as orexin receptor antagonists |
01/14/2010 | CA2729833A1 Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof |
01/14/2010 | CA2727651A1 Anti-infective compounds |
01/14/2010 | CA2727282A1 Novel pyrrolidine derivatives as metap-2 inhibitors |
01/13/2010 | EP2143724A1 Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes |
01/13/2010 | EP2142544A1 Pyrido [2, 3-d]pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer |
01/13/2010 | EP2142543A1 Pyrido [2, 3-d]pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer |
01/13/2010 | EP2142528A1 1-(1-benzylpiperidin-4-yl)benzimidaz0le -5-carboxylic acid derivatives for the treatment of diabetes mellitus |
01/13/2010 | EP2142509A2 Quinolones and azaquinolones that inhibit prolyl hydroxylase |
01/13/2010 | EP2141990A1 11beta-hsd1 active compounds |
01/13/2010 | CN101627039A Spiro (furo [3, 2-c] pyridine-3-3 ' -indol) -2' (1'h)-one derivatives and related compounds for the treatment of sodium-channel mediated diseases, such as pain |
01/13/2010 | CN101624393A Method for extracting cytosine and thermopsine from thermopsis lanceolata seeds |
01/13/2010 | CN101624391A Thiophene derivatives as antiviral agents for flavivirus infection |
01/13/2010 | CN100579980C Ru(II) complex with anticancer liveness and method for preparing the same |
01/13/2010 | CN100579979C 7-phenylpyrazolopyridine compounds |
01/13/2010 | CN100579978C Compounds |
01/13/2010 | CN100579976C P38 inhibitors and methods of use thereof |
01/13/2010 | CN100579518C Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
01/12/2010 | US7645781 N-aryl-2-oxazolidinone-5-carboxamides and their derivatives |
01/12/2010 | US7645770 Phenylalanine enamide derivatives |
01/12/2010 | US7645769 Inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders relating to apoptosis and/or inflammation |
01/12/2010 | US7645764 Kinase inhibitors and methods for using the same |
01/12/2010 | US7645761 Indoline derivatives |
01/12/2010 | US7645757 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors |
01/12/2010 | CA2407838C Pyrano, piperidino, and thiopyrano compounds and methods of use |
01/12/2010 | CA2407463C N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
01/12/2010 | CA2306428C 3-oxo-2(h)-1,2,4 - triazine derivatives as ligands of 5ht1a receptors |
01/07/2010 | WO2010003048A1 Benzimidazoles and related analogs as sirtuin modulators |
01/07/2010 | WO2010003025A1 Bicyclic heterocycles as mek kinase inhibitors |
01/07/2010 | WO2010002998A1 2,4,6-TRISUBSTITUTED PYRIDO (3,2-d) PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS |
01/07/2010 | WO2010002956A2 Heterocyclic derivatives as modulators of ion channels |
01/07/2010 | WO2010002820A1 Aza-indoles and related compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
01/07/2010 | WO2010002779A2 Naphthyridininones as aurora kinase inhibitors |
01/07/2010 | WO2010002483A1 Optionally condensed dihydro pyridine, dihydropyrimidine and dihydro pyrane derivatives acting as late sodium channel blockers |
01/07/2010 | WO2010002451A1 Naphthyridin derivatives |
01/07/2010 | WO2010001408A2 Novel polymorphic forms of gemifloxacin mesylate |
01/07/2010 | WO2010000364A1 Pyrrolopyridinylpyrimidin-2-ylamine derivatives |
01/07/2010 | WO2010000032A1 Compounds having antiviral properties |
01/07/2010 | WO2009140128A3 Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors |
01/07/2010 | WO2009131687A3 Inhibitors of protein kinases |
01/07/2010 | WO2009129259A3 Polymorphs of 5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-n-(1-methylpiperidin-4-yl)-9h-pyrido[2,3-b]indole-7-carboxamide and methods of use therefor |
01/07/2010 | WO2009007536A8 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics |
01/07/2010 | WO2008149168A8 Triazolo [1, 5-a] quinolines as adenosine a3 receptor ligands |
01/07/2010 | US20100004451 Varenicline tosylate, an intermediate in the preparation process of varenicline l-tartrate |
01/07/2010 | US20100004447 Process for preparation of 9-hydroxy-3-(2-chloroethyl)-2-methyl-4h-pyrido[1,2-a]pyrimidin-4-one hydrochloride |
01/07/2010 | US20100004281 Viral inhibitors |
01/07/2010 | US20100004280 Substituted imidazoles as bombesin receptor subtype-3 modulators |
01/07/2010 | US20100004269 5-anilinoimidazopyridines and methods of use |
01/07/2010 | US20100004260 2-piperazin-1-yl-3h-imidazo[4,5-b]pyridine derivatives |
01/07/2010 | US20100004241 Non-imidazole aryloxyalkylamines |
01/07/2010 | US20100004239 Pyrrolo [3,2-C] Pyridine-4-One 2-Indolinone Protein Kinase Inhibitors |
01/07/2010 | US20100004237 (S)-2-Amino-6-benzyl-7-[4-fluoro-2-(2-fluoro-pyridin-3-yl)-phenyl]-4-methyl-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-one;cellular proliferative, viral, autoimmune, cardiovascular, and central nervous system diseases; heat-shock protein 90 (HSP90) inhibitor |